. Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology. 2001 Feb 13;56(3):361-7. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. What does AD type pathology mean since the patients can be normal? Do we need better preclinical tests?

Make a Comment

To make a comment you must login or register.